[1] |
Meyer V, Beissert S. Azathioprine in the treatment of autoimmune blistering diseases[J]. Dermatol Clin, 2011, 29(4): 545⁃554. DOI: 10.1016/j.det.2011.06.009.
|
[2] |
Roberts RL, Barclay ML. Update on thiopurine pharmacogenetics in inflammatory bowel disease[J]. Pharmacogenomics, 2015, 16(8): 891⁃903. DOI: 10.2217/pgs.15.29.
|
[3] |
Tanaka Y, Kato M, Hasegawa D, et al. Susceptibility to 6⁃MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia[J]. Br J Haematol, 2015, 171(1): 109⁃115. DOI: 10.1111/bjh.13518.
|
[4] |
Amagai M, Tanikawa A, Shimizu T, et al. Japanese guidelines for the management of pemphigus[J]. J Dermatol, 2014, 41(6): 471⁃486. DOI: 10.1111/1346⁃8138.12486.
|
[5] |
Hertl M, Jedlickova H, Karpati S, et al. Pemphigus. S2 Guideline for diagnosis and treatment--guided by the European Derma⁃tology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)[J]. J Eur Acad Dermatol Venereol, 2015, 29(3): 405⁃414. DOI: 10.1111/jdv.12772.
|
[6] |
Kim JH, Cheon JH, Hong SS, et al. Influences of thiopurine methyltransferase genotype and activity on thiopurine⁃induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study[J]. J Clin Gastroenterol, 2010, 44(10): e242⁃248. DOI: 10.1097/MCG.0b013e3181d6baf5.
|
[7] |
Dewit O, Moreels T, Baert F, et al. Limitations of extensive TPMT genotyping in the management of azathioprine⁃induced myelo⁃suppression in IBD patients[J]. Clin Biochem, 2011, 44(13): 1062⁃1066. DOI: 10.1016/j.clinbiochem.2011.06.079.
|
[8] |
Moriyama T, Nishii R, Perez⁃Andreu V, et al. NUDT15 polymor⁃phisms alter thiopurine metabolism and hematopoietic toxicity[J]. Nat Genet, 2016, 48(4): 367⁃373. DOI: 10.1038/ng.3508.
|
[9] |
Lee YJ, Hwang EH, Park JH, et al. NUDT15 variant is the most common variant associated with thiopurine⁃induced early leuko⁃penia and alopecia in Korean pediatric patients with Crohn′s disease[J]. Eur J Gastroenterol Hepatol, 2016, 28(4): 475⁃478. DOI: 10.1097/MEG.0000000000000564.
|
[10] |
刘忠, 庄娘桥, 雷丽华, 等. 硫唑嘌呤致骨髓抑制三例[J]. 中华皮肤科杂志, 2006, 39(7): 414.
|